Objective: Patients with chronic pancreatitis suffer from malabsorption and nutritional deficiencies. However there is little data available concerning the fatty acid profile in chronic pancreatitis. Diabetes mellitus, a common complication of this disease, could interfere with the metabolism of fatty acids. Subjects: We therefore compared the fatty acid composition of LDL from four groups of male patients with (a) chronic pancreatitis without diabetes (ND-CP; n ¼ 12), (b) diabetes secondary to chronic pancreatitis and insulin-treated (CP-D; n ¼ 35); (c) type 1 diabetes (n ¼ 25); and (d) controls (n ¼ 20). Results: The patients in both groups of chronic pancreatitis (ND-CP and CP-D) had lower mean values for linoleic acid than that seen in the type 1 DM and control groups, whereas monounsaturated fatty acids (MUFA; 18 : 1(n-9) and (16 : 1(n-7)) were significantly increased in these two groups (ND-CP and CP-D). Docosa-hexaenoic-acid (22 : 6(n-3)) was significantly decreased in the CP-D group (P > 0.05), a response that could be explained by the effects of diabetes mellitus and by selenium deficiency. In this way, diabetes was associated with a decrease in the docosa-hexaenoic-acid (22 : 6(n-3); r ¼ 0.30, P ¼ 0.005), and selenium was correlated with DHA (r ¼ 0.28, P ¼ 0.029) and with the 22 : 6(n-3)=20 : 5(n-3) ratio (evaluating the delta 4 desaturation); r ¼ 0.31, P ¼ 0.022), independently of the diabetes effect. Selenium was negatively correlated with 20 : 4(n-6)/ 20 : 3(n-6) ratio (evaluating the delta 5 desaturase; r ¼ -0.30; P ¼ 0.025). These results suggest that these two factors may have a role in the regulation of the desaturation process. If we consider that a ratio of 16 : 1(n-7)=18 : 2(n-6) greater than 0.086 in plasma indicates an EFAn-6 deficiency, 40% of our CP patients, 57.6% of CP-D patients and 13.6% of type 1 DM patients were involved. Conclusions: The consequences of these deficiencies are not evaluated in this disease. However, correction of the fundamental deficiencies in essential fatty acids and in selenium seems desirable in chronic pancreatitis.
Introduction
Patients with chronic pancreatitis suffer from malabsorption and nutritional deficiencies. Malabsorption of fat, the catabolic stress of illness and weight loss enhance the risk of essential fatty acid deficiencies. However there is little data available concerning the fatty acid profile in chronic pancreatitis. It has been proposed that diabetes mellitus, a common complication of chronic pancreatitis, could interfere with the metabolism of fatty acids (Mimouni et al, 1994; Poisson, 1989; Clark & Queener, 1985) . Desaturase activities could also be affected in diabetes mellitus and be dependent on insulin (el Boustani et al, 1989) . Furthermore, it has been suggested that zinc and selenium could play a role in the desaturation of n-3 and n-6 polyunsaturated fatty acids (Clejan et al, 1982; Infante, 1986; Celik et al, 1999) . To this end, we have already shown (Quilliot et al, 2001 ) that the plasma zinc concentration was below normal in chronic pancreatitis patients, and that plasma selenium concentra-tions were lower in chronic pancreatitis patients than in healthy controls. Furthermore, we showed that diabetes mellitus, a common complication of chronic pancreatitis, could increase zinc and selenium deficiencies. The aim of the present study was to describe the fatty acid pattern in chronic pancreatitis and to evaluate the effects of concomitant diabetes mellitus.
It is clearly demonstrated that the LDL fatty acid composition reflects the composition of dietary fat intake (Thomas & Rudel, 1996) . Moreover, the effect of diet on the composition of lipoproteins and the relationship between fatty acid composition and clearance is well established (von Schacky, 2000; Tomkin & Owens, 2001) . We therefore compared the fatty acid composition of LDL from patients suffering from diabetes mellitus secondary to chronic pancreatitis with (1) that of type 1 diabetic patients, (2) that of patients with chronic pancreatitis but without diabetes, and (3) that of controls. We also analyzed the effect of diabetes mellitus and of malabsorption of fat on LDL fatty acid pattern.
Research design and methods
Ninety-two male subjects were enrolled in the study. The subjects were classified into one of four groups made up of (a) those with chronic pancreatitis without diabetes (ND-CP; n ¼ 12), (b) those with diabetes secondary to chronic pancreatitis and insulin-treated (CP-D; n ¼ 35), (c) those having type 1 diabetes (n ¼ 25), and (d) controls (n ¼ 20). The patients with type 1 diabetes mellitus were individually matched for age and diabetes duration ( AE 2 y) with the CP-D patients. The healthy control subjects were matched for social category and age with the ND-CP patients (Table 1) . They were selected among the technical personnel of the hospital, working as plumber, mechanic, electrician, stretcher-bearer and some unemployed persons. They were recruited after a cross-examination and a blood screening.
Chronic pancreatitis was diagnosed on the basis of clinical history and the presence of morphological pancreatic abnormalities, especially calcification detected by X-ray and confirmed by abdominal ultrasonography, computerized tomography or echoendoscopy. All CP-D and 10=12 ND-CP patients had calcific pancreatitis. One patient was diagnosed by ultrasonography scanner and another by echoendoscopy.
All patients in the CP-D group had ceased or greatly reduced their alcohol intake by the time of the study (Table 2) . Upon entry into the study they had consumed alcohol at less than 30 g=day for 5 years. Their alcohol consumption prior to this had been 111 AE 66 g =day on average (range: 50 -450 g=day) for a period of 25.5 AE 11.4 years. Three of these patients had undergone choledocojejunostomies and four had undergone cystic derivations. Patients with pancreatectomy or gastrectomy were excluded from the study.
All patients in the CP-D group had diabetes according to the criteria of the American Diabetes Association (Report of the Expert Commitee on the Diagnosis and Classification of Diabetes Mellitus, 1997) and had been on insulin for at least 3 months. No patient had suffered from acute pancreatitis for the previous 3 months. All patients in the ND-CP group had normal fasting plasma glucose on the day they entered the study (fasting plasma glucose < 6.1 mmol=l; Table 1 ). 
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Patients treated with pancreatic enzymes underwent a 5-day washout period. Seventy-two-hour stools were collected from chronic pancreatitis patients on a home-cooked diet. Blood samples were collected after an overnight fast, prior to insulin injection, and then on the sixth day of the washout period. This study was approved by the ethical committee of CHU de Nancy (France).
Analytical methods
Plasma glucose concentrations were measured by the glucose oxidase method using an automated glucose analyzer. HbAc 1 c was determined as a percentage of total hemoglobin following high performance liquid chromatography (Diamat, BioRad laboratories, Hercules, CA, USA; normal range 4.5 -6%).
The content of fecal fat from patients in the Chronic Pancreatitis groups was analyzed according to Van de Kamer et al (1949) . Steatorrhea was considered abnormal when higher than 5 g=day.
HDL-cholesterol was obtained after precipitation of apo Bcontaining lipoproteins with sodium phosphotungstate=magnesium chloride (Boehlringer Mannheim, Germany). Total cholesterol and triglycerides were determined using commercial kits (Boehringer, Mannheim, Germany) adapted to an Hitashi 911 analyzer (Japan). LDL-cholesterol was calculated according to Friedewald et al (1972) . Apo B was measured by immunonephelemetry (Behring, Marburg, Germany). An atomic absorption spectrophotometer was used to measure zinc (normal range 0.7 -1.1 mg=l) and selenium (normal range 60 -83 mg=l) concentrations using the method of Clavel et al (1983) .
Determination of the fatty acid composition of LDL
The fatty acid composition of LDL was determined after lipid extraction (Folch et al, 1957) . Lipids were methanolized with methanolic H 2 S0 4 for 2 h at 70 C. Fatty acid methyl esters were extracted with heptane and analyzed by gas chromatography on a Varian 3400 chromatograph (Sunnyvale, CA, USA) equipped with flame ionization detector and a capillary WCOT fused Silica 88 column containing cyanopropylplysiloxane (Chrompack, Middelburg, The Netherlands).
Data analysis
Conventional methods were used to calculate means AE s.d. Statistical analyses were performed with BMDP software (Berkeley, CA, USA). Continuous variables were tested by analysis of variance (ANOVA) over the four groups. The Sheffé's comparison test was applied when ANOVAs were significant. Pearson's correlation was used for two-variable relationships. Multiple regression analysis was used to assess the effects of several independent variables on fatty acids concentration. In the multiple regression analysis, we took account of the effects of diabetes mellitus (diabetics vs without diabetes mellitus) and of chronic pancreatitis (with chronic pancreatitis vs without chronic pancreatitis). A value of P < 0.05 was considered significant.
Results
The clinically relevant characteristics of the four groups of subjects are shown in Table 1 . Chronic pancreatitis patients had a lower body mass index (BMI) than type 1 DM and control patients (P < 0.0001). Controls and non-diabetic CP patients were younger than the CP-D and type 1 DM patients (P < 0.001). Non-diabetic CP patients had chronic pancreatitis for a shorter time than the CP-D patients (P < 0.05). Current smoking habits were similar for the two groups of patients with diabetes mellitus, but the CP-D group had formerly been heavier smokers (P < 0.00l) ( Table 2) . Alcohol consumption on enrollment was lower in the two groups of chronic pancreatitis than in the control group (P < 0.05).
The mean values of daily nutrient intake are shown in Table 2 . Fat consumption was not significantly decreased in both groups of chronic pancreatitis (ND-CP and CP-D), whereas there was a significant increase in the energy intake in the control group. In Diet, the proportion of polyunsaturated, monounsaturated and saturated fatty acids was not significantly different among the four groups.
The patients from both chronic pancreatitis groups (ND-CP and CP-D) had a lower plasma LDL-cholesterol concentration than the controls and type 1 DM patients (Table 3) . There were no significant differences in the plasma HDLcholesterol and triglycerides between the four groups.
The plasma zinc concentration was below normal in both groups of chronic pancreatitis patients but was signifi- Fatty acid abnormalities in chronic pancreatitis D Quilliot et al cantly low in the CP-D group (P < 0.01), with 17% having below 0.7 mg=l. The plasma selenium concentrations were lower in both groups of chronic pancreatitis (CP and CP-D) patients than in the healthy controls (P < 0.000l) and 41% of them and 12% of type 1 DM were selenium-deficient ( < 60 mg=l; detailed in Quilliot et al, 2001) . Table 4 lists the percentages of the LDL fatty acid pattern. The major form of the n-6 family was linoleic acid (18 : 2(n-6)), and for the n-3 family it was docosa-hexaenoic acid (DHA) (22 : 6(n-3)). The percentage of derived fatty acids in the n-9 family (DFA9) was low in all four groups compared with essential n-3 and n-6 families.
The patients in both groups of chronic pancreatitis (ND-CP and CP-D; Table 4 and Figure 1 ) had lower mean values for linoleic acid than patients from the type 1 DM and control groups, whereas monounsaturated fatty acids (MUFA); 18 : 1(n-9) and 16 : 1(n-7)) were significantly increased in the two chronic pancreatitis groups (ND-CP and CP-D). Total saturated fatty acids were not significantly different in the four groups.
In both groups of chronic pancreatitis patients, the direct fatty acid precursor of the 18 : 1 (n-9) (stearic acid: 18 : 0) was decreased. On the other hand, the two indexes of delta 9 desaturase activities (16 : 1(n-7)=16 : 0 and 18 : 1(n-9)=18 : 0) increased in both groups.
We did not find any relation between monounsaturated fatty acids and steatorrhea, BMI or LDL-cholesterol. However the post-prandial apo B-48 concentration, which is a more sensitive marker of fat malabsorption (Saviana et al, 1999) , was significantly and positively correlated with the linoleic acid (r ¼ 0.35; P ¼ 0.038) concentration in a subgroup of the DHA and the 22 : 6(n-3)=20 : 5(n-3) ratio (evaluating delta 4 desaturation activity) were significantly decreased in the Figure 1 Fatty acid profile of LDL in chronic pancreatitis subjects: ratio of LDL fatty acid in chronic pancreatitis to healthy control. *P < 0.05 vs controls; **P < 0.01 vs controls; ***P < 0.001 vs controls.
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D Quilliot et al CP-I) group. No difference was found in a comparison of the fatty acid pattern of type 1 DM and controls. The proportion of precursor fatty acids (PFA) was not altered and the mean 16 : 1 (n-7)=18 : 2(n-6) ratio did not increase in type 1 DM patients compared to control. A statistical multivariate analysis of the whole population confirmed that chronic pancreatitis per se may decrease polyunsaturated fatty acids (especially linoleic acid ( For the entire population of subjects, DHA and the 22 : 6(n-3)=20 : 5(n-3) ratio (evaluating delta 4 desaturation activity) was positively correlated with the selenium concentration (r ¼ 0.28, P ¼ 0.029 and r ¼ 0.31, P ¼ 0.022, respectively), even if adjusted in a multiple regression analysis for the diabetes and the chronic pancreatitis. Selenium was also positively correlated with the 20 : 4(n-6)=20 : 3(n-6) ratio (r ¼ 0.25; P ¼ 0.025); evaluating delta 5 desaturase activity); a correlation which remained significant after adjustment for diabetes mellitus and chronic pancreatitis.
A stepwise analysis showed that DHA was negatively correlated with selenium (first step: r 2 ¼ 11.2) and with diabetes mellitus (second step: r 2 ¼ 19.4). No correlation was found between selenium concentration and delta 6 desaturase activity. Zinc concentration was not correlated with any of the fatty acid patterns.
Discussion
In this study, we showed that patients with chronic pancreatitis had a decrease in LDL linoleic acid content compared with type 1 DM and control groups, whereas monounsaturated fatty acids (MUFA);18 : 1 (n-9) and 16 : 1 (n-7)) were significantly increased. Among the o-3 fatty acids, we observed a significantly decreased DHA (22 : 6(n-3)) content that could be explained by the effects of diabetes mellitus and by selenium deficiency.
It is likely that fat malabsorption in chronic pancreatitis explains the decrease in the proportion of linoleic acid. Steatorrhea was significantly elevated in these patients and we did not find any differences between the chronic pancreatitis and type 1 diabetic groups in relation to dietary unsaturated fatty acids. Consequently EFA deficiencies are not due to decreased intakes. However, the measurement of feces is a crude marker of exocrine pancreatic insufficiency (DiMagno et al, 1973) . This would explain the fact that, in this study, we did not find any relation between steatorrhea and the fatty acid pattern of LDL. Drug-induced steatorrhea, using tetrahydrolipostatin, a lipase inhibitor (Orlistat), gives rise to the same reduction in linoleic acid (Vidgren et al, 1999) . Moreover, the post-prandial apo B-48 concentration, which is a more sensitive marker of fat malabsorption (Saviana et al, 1999) , was significantly and positively correlated with the linoleic acid concentration in a subgroup of CP patients (data not shown). In cystic fibrosis patients, Clandinin et al (1995) found also a decrease in plasma linoleic acid concentration independently of pancreatic function. Siguel and Lerman (1996) have shown that a ratio of 16 : 1(n-7)=18 : 2(n-6) greater than 0.086 in plasma is indicative of an EFAn-6 deficiency, which in the present study was the case for 40% of our CP patients and 57.6% of CP-D patients.
The increase in oleic acid and palmitoleic concentrations offset the decreased LDL linoleic acid content. The higher percentage of 18 : 1(n-9) is not due to a higher percentage of direct precursor (18:0); on the contrary, this fatty acid decreased in these patients, suggesting that synthesis from stearic fatty acid is greater. The increase in the ratios 16 : 1(n-7)=16 : 0 and 18 : 1(n-9)=18 : 0 in both groups of chronic pancreatitis patients suggests that delta 9 desaturase activity increased in these subjects. On the other hand, oleic acid could be less affected by lipase deficiency or lipase inhibition (Fernandez & Borgstrom, 1989) .
We are nevertheless cautious about the use of the fatty acids plasma ratio to evaluate the activities of delta desaturase. In fact, liver microsomal fatty acid desaturases are not always consistent with microsomal fatty acid composition (Mimouni et al, 1992) or with plasma fatty acid pattern (Brown et al, 2000) .
In the malabsorption syndrome, studies have shown that essential fatty acids deficiency may affect the metabolism of fatty acids (Siguel & Lerman, 1994 Clandinin et al, 1995) . However, even if linoleic acid decreased, the percentage of arachidonic acid was not altered. Its synthesis was thus preserved.
Our results showed that selenium was negatively and independently correlated with the 20 : 4(n-6)=20 : 3(n-6) ratio, suggesting that selenium could affect delta 5 desaturase activity. The reduced levels of 22 : 6(n-3) (DHA) in the CP-D group could be explained by a decrease in delta 4 desaturation activity as assessed by the 22 : 6(n-3)=20 : 5(n-3) ratio. This finding suggests, but does not necessarily prove, the fact that diabetes mellitus and selenium deficiency may play a role in the regulation of the desaturation process. The final step in DHA synthesis involves elongation, then delta 6 desaturation and partial b-oxidation (Sprecher, 1992; Voss et al, 1991) . Selenium could be implicated in the peroxisomal beta oxidation, which is increased with the dietary selenium content (Glauert et al, 1990) . Moreover, in healthy subjects, serum selenium was the only variable predictive of the unsaturated index of plasma phospholipids (Cabre et al, 1992) .
It was surprising that the precursor of the fatty acids of the n-3 family, 18 : 3 (n-3), was not affected by fat malabsorption. Similar results have been observed with a lipase inhibitor (Orlistat) and in cystic fibrosis. In this disease, 18 : 3(n-3) Fatty acid abnormalities in chronic pancreatitis D Quilliot et al could be elevated (Rosenlund et al, 1977) because, as in our study, the products from it were very significantly deficient.
We did not observe any modifications in the fatty acid pattern of type 1 DM patients. However, if we consider a 16 : 1(n-7)=18 : 2(n-6) ratio greater than 0.086, then three out of 25 type I DM patients were involved. Consequently, these subjects could be at higher risk of EFA n-6 deficiencies. Moreover, a decrease in linoleic acid was observed in diabetes mellitus (Salomaa et al, 1990) . A selenium deficiency could accentuate the DHA deficiency in these patients. The effect of dietary selenium supplementation on the fatty acid pattern, especially in DHA, remains to be evaluated in chronic pancreatitis. However, the high prevalence of low plasma selenium concentration in these patients (Quilliot et al, 2001; Wiedmann et al, 1988) justifies the use of daily supplementation.
We did not find any effect of zinc deficiency in the study population. These results are in accordance with Eder and Kirchgessner (1996) , who found no effect of zinc deficiency on the desaturation of linoleic and alpha linolenic acid. The consequences of these deficiencies are not evaluated in this disease. For example, atherogenesis is accelerated in patients with diabetes secondary to chronic pancreatitis, even though they have even lower plasma LDL cholesterol concentrations (Ziegler et al, 1994; Gullo et al, 1982; Sjoberg & Kidd, 1989; Oliver 1981 ). As such, populations with low levels of linoleic acid have a higher incidence of coronary artery disease (Oliver, 1981) . On the other hand, a low level of linoleic acid could be implicated in the insulin-resistance syndrome (Vessby, 2000) . As knowledge on the functional roles of n-3 and n-6 fatty acids and their oxygenated products accumulates, this will be translated into recommendations for dietary fatty acids to prevent such deficiencies. Correction of a fundamental EFA deficiency seems desirable in patients with chronic pancreatitis, above all in case of concomitant diabetes mellitus. However, supplementation with a very rich source of linoleic acid and DHA remains to be evaluated.
